Barclays analyst Luke Sergott maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $24.00. The company’s...
Total operating expenses for 2022 were $564 million compared to $468.7 million for 2021. The increase in operating expenses was primarily driven by an increase in personnel expenses, including stock-based compensation expense, and higher costs for facilities and information technology to support operati...
Current Price $48.02 NYSE: BHC Bausch Health Companies Market Cap $3B Current Price $8.26 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
we did hear some things towards the end of the quarter of service providers just with having recession fears in general, wanting to carry less inventory overall. So I think it’s more activity driven than stock driven.